Cadre Q1 2026 Earnings Miss: Net Income Plunges to $2M Amid Strong Sales

What happened

Cadre Holdings reported Q1 2026 net sales of $155.4 million, up from prior periods, but net income collapsed to $2.0 million ($0.05 per share), a dramatic decline from the $12.2 million earned in Q2 2025 and well below the $0.23 EPS reported in Q1 2025. Gross margin of 38.7% was decent but not enough to offset what appears to be rising operating expenses or acquisition-related costs from the Zircaloy deal. The latest DeepValue analysis had flagged a premium valuation (P/E 44x) and lumpy free cash flow as key risks, and this quarter's earnings miss validates those concerns. Management's narrative of strong demand and a $186 million backlog may be real, but the bottom-line shortfall suggests that revenue growth is not flowing through to profits as expected. Investors should question whether this is a one-time hiccup or the start of a trend of margin compression.

Implication

The Q1 2026 miss highlights that Cadre's elevated P/E multiple (44x at the time of the master report) is not backed by consistent earnings power. Investors should reconsider the HOLD thesis if profitability does not rebound in coming quarters. The $2 million net income implies a run-rate far below the $36 million earned in FY2024, raising doubts about full-year guidance if any. While the backlog and defense tailwinds remain positive, the company must demonstrate that it can convert sales into profit reliably. Until then, the risk-reward skews negative, and a SELL downgrade could be warranted if next quarter shows no improvement.

Thesis delta

The master report recommended HOLD given full valuation but solid fundamentals. The Q1 2026 earnings collapse introduces a new risk: even with strong sales, profitability can be severely impaired. This shifts the thesis from a neutral wait-and-see to a more bearish posture, as the premium valuation now lacks earnings support.